TGTX

Charney Laurence N

Known title: DirectorCIK: 0001407451

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

TGTX Highlighted as Affordable Biotech Growth Play. ChartMill recently featured TG Therapeutics as an affordable growth option within the biotech sector. This analysis suggests the stock may be viewed as undervalued relative to its potential, despite trading near its 52-week low. The mention adds a positive fundamental perspective to the current technical setup.

this person other insiders at TGTX

Transaction History

TGTX▼ Sell$275K
TGTX▼ Sell$0
TGTX▼ Sell$0
TGTX▼ Sell$0
TGTX▼ Sell$0
TGTX▼ Sell$0
TGTX▲ Buy$0
TGTX▼ Sell$0
TGTX▼ Sell$0
TGTX▼ Sell$755K
TGTX▲ Buy$0
TGTX▼ Sell$351K
TGTX▼ Sell$333K
TGTX▲ Buy$0
TGTX▼ Sell$333K
TGTX▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.